Oral characteristics of bergenin and the effect of absorption enhancers in situ, in vitro and in vivo

Arzneimittel-Forschung/Drug Research

Volumn 60, Issue 4, 2010, Pages 198-204

  Qin, Xuan ^a   Yuan, Fang ^a   Zhou, Dan ^a   Huang, Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Absorption enhancers; Bergenin, bioavailability, oral absorption, pharmacokinetics; Caco 2 cell monolayer

Indexed keywords

BERGENIN; BORNEOL; POLOXAMER;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DIFFUSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG PENETRATION; GASTROINTESTINAL ABSORPTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RAT;

EID: 77951712734     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296273     Document Type: Article

References (45)

1. Nazir N, Koul S, Qurishi MA, Taneja SC, Ahmad SF, Bani S, et al. Immunomodulatory effect of bergenin and norbergenin against adjuvant-induced arthritis-a flow cytometric study. J Ethnopharmacol. 2007;112:401-405 (Pubitemid 46778958)
2. Ye YP, Sun HX, Pan YJ. Bergenin monohydrate from the rhizomae of Astilbe chinensis. Acta crystallogr C. 2004;60:397-398.
3. Chinese Pharmacopoeia Commission. The Pharmacopoeia of the People's Republic of China. 2005; part I: 278.
4. Hack SK, Hwa KL, Myeon WC, Young CK. Antihepatotoxic activity of bergenin, the major constituent of Mallotus japonicus, on carbon tetrachloride-intoxicated hepatocytes. J Ethnopharmacol. 2000;69:79-83.
5. Wang G, Ma J, Overview of Recent Progress on bergenin. Anhui Zhong Yi Xue Yuan Xue Bao. 2002;21:59-62.
6. Lim HK, Kim HS, Choi HS, Choi J, Kim SH, Chang MJ, Effects of bergenin, the major constituent of Mallotus japonicus against D-galactosamine-induced hepatotoxicity in rats. Pharmacology. 2001;63:71-75 (Pubitemid 32718883)
7. Piacente S, Pizza C, Tommasi N, Mahmood N. Constituents of Ardisia japonica and their in vitro anti-HIV activity. J Nat Prod. 1996;59:565-569 (Pubitemid 26239363)
8. Takahashi H, Kosaka M, Watanabe Y, Nakade K, Fukuyama Y. Synthesis and neuroprotective activity of bergenin derivatives with antioxidant activity. Bioorg Med Chem. 2003;11:1781-1788 (Pubitemid 36349159)
9. Jiangsu NewMedical College. Traditional Medicine. Shanghai: People press; 1999; p. 2359.
10. Wang G, Liu JK, Ma BJ, inventors. Chen Z, assignee. The acetylate of bergenin and its application. P. R. China patent 200510010970.0. 2006.
11. Cyril R, Olivier RM. Synthesis of bergenin-related natural products by way of an intramolecular C-glycosylation reaction. Tetrahedron Asymmetr. 2000;11:409-412.
12. Li XD, Lu SL, He B, inventors. Liu AN, assignee. The preparation of bergenin compositae pills. P. R. China patent 200410040660.9. 2005.
13. Li J, inventor. The preparation of bergenin compositae soft capsules. P. R. China patent 200410078846.3. 2005.
14. Guan JY, Sun DJ, Wu GL. The study of bergenin's inclusion complex. Zhong Cheng Yao. 1991;13:4-5.
15. Shinya T, Takeo K, Takahiro M, Yuji H, Hiroyuki Y. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. Eur J Pharm Biopharm. 2006;62:52-58.
16. Aungst BJ. Intestinal permeation enhancers. J Pharm Sci. 2000;89:429-442.
17. Feng L, Jiang XH. Absorption profiles of sanchinoside R1 and ginsenoside Rg1 in the rat intestine. Eur J Drug Metab Pharmacokinet. 2005;30:261-268.
18. Bermejo MV, Pérez-Varona AT, Segura-Bono MJ, Martín- Villodre A, Pla-Delfina JM, Garrigues TM. Compared effects of synthetic and natural bile acid surfactants on xenobiotic absorption I. Studies with polysorbate and taurocholate in rat colon. Int J Pharm. 1991;69:221-231.
19. Teodoro Z, María JC, Ricardo NM, Consuelo G, Luis G, Ana P. Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models. Eur J Pharm Sci. 2004;22:347-356.
20. Schurgers N, Bijdendijk J, Tukker J, Crommelin D. Comparison of four experimental techniques for studying drug absorption kinetics in the anesthetized rat in situ. J Pharm Sci. 1986;75:117-119 (Pubitemid 16162531)
21. Sawamoto T, Haruta S, Kurosaki Y, Higaki K, Kimura T. Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability. J Pharm Pharmacol. 1997;49:450-457 (Pubitemid 27207703)
22. Xuan Q, Dan Z, Zhi RZ, Yuan H. Determination of bergenin in rat plasma by high-performance liquid chromatography. Pharmazie. 2007;62:323-326 (Pubitemid 46847932)
23. Ren J, Jiang XH, Li C, Li K, Chen Z, Ma G. Absorptive profile of chlorogenic acid in rats. Pharmazie. 2007;62:689-692 (Pubitemid 47507843)
24. Tsuji A, Miyamoto E, Kagami I, Sakaguchi H, Yamana T. GI absorption of beta-lactam antibiotics I: kinetic assessment of competing absorption and degradation in GI tract. J PharmSci. 1978;67:1701-1704 (Pubitemid 9086690)
25. Pratima S, Gupta RC. In situ absorption and protein binding characteristics of CDRI-85/92, an antiulcer pharmacophore. Int J Pharm. 2003;257:97-102.
26. Barbra H, Stewart O, Helen C, Nancy J. Discrimination between drug candidates using models for evaluation of intestinal absorption. Adv Drug Deliver Rev. 1997;23:27-125.
27. Dan Z, Xuan Q, Zhi RZ, Yuan H. Physicochemical properties of bergenin. Pharmazie. 2008;63:366-371.
28. Sibylle N, Anna-Lena U, Ismael Z, Per A. pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers. Eur J PharmSci. 2005;25:211-220.
29. Lipka E, Amidon GL. Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems. J Control Release. 1999;62: 41-49 (Pubitemid 29486480)
30. Shrutidevi A, Ramesh P. Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms. Biopharm Drug Dispos. 2005;26:321-334.
31. 125I- cobrotoxin after intranasal administration to the brain: A microdialysis study in freely moving rats. Int J Pharm. 2007; 328:161-167.
32. Yong CS, Yang CH, Rhee JD, Lee BJ, Kim DC, Kim DD, et al. Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol. Int J Pharm. 2004;269:169-176.
33. Hui BX, Kai XH, Yu SZ, Qiu HG, Qing ZW, Wei QT, et al. Hypoglycaemic effect of a novel insulin buccal formulation on rabbits. Pharmacol Res. 2002;46:459-467.
34. Zhu JP, Wang ZR, Wu NX. [Enhanced percutaneous penetration with borneol]. Zhongguo Yao Xue Za Zhi. 1999;34:104-106.
35. Wang H, Xu WR, Wang ZR. [Effect of 1-menthol and synthetic borneol on enhanced percutaneous penetration]. Zhong Cao Yao. 1997;28:93-95.
36. Chen YM, Wang NS. Effect of borneol on P-glycoprotein. Tradit Chin Drug Res Clin Pharmacol. 2003;14:96-99.
37. Chen YM, Wang NS. [Effect of borneol on the intercellular tight junction and pinocytosis vesicles in vitro blood-brain barrier model]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004;24:632-634.
38. Kotzé AF, Thanou MM, Lueßen HL, Boer AG, Verhoef JC, Junginger HE. Effect of the degree of quaternization of Ntrimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). Eur J PharmBiopharm. 1999;47:269-274.
39. Belsito D, Bickers D, Bruze M, Calow P, Greim H, Hanifin JM, et al. A toxicologic and dermatologic assessment of cyclic and non-cyclic terpene alcohols when used as fragrance ingredients. Food Chem Toxicol. 2008;46:S1-S71.
40. Xiao YY, Ping QN, Chen ZP. The enhancing effect of synthetical borneol on the absorption of tetramethylpyrazine phosphate in mouse. Int J Pharm. 2007;337:74-79.
41. Li XR, Xu W, Feng YF. [Effects of borneol or menthol on nitrendipine absorption in rabbit]. Zhongguo Yi Yuan Yao Xue Za Zhi. 2001;21:264-266.
42. Lin ZZ, Yao MC, Lan MX, Liu PJ, Zhong GP, Pi RB. [Effect of borbeol on distribution of sodium ferulate in plasma and in brain regions of mice]. Zhong Cao Yao. 2000;39:551-556.
43. Edward LL, Steven CS. In vitro models for selection of development candidates: Permeability studies to define mechanism of absorption enhancement. Adv Drug Deliv Rev. 1997;23:163-183.
44. Alamdar H, John JA, Mansoor AK, Fakhrul A. Absorption enhancers in pulmonary protein delivery. J Control Release. 2004;94:15-24.
45. Schipper NG, Värum KM, Stenberg P, Ocklind G, Lennernäs H, Artursson P. Chitosans as absorption enhancers of poorly absorbable drugs: Influence of mucus on absorption enhancement. Eur J PharmSci. 1999;8:335-343 (Pubitemid 29325026)